Camber Launches Generic Neurontin®

Key Takeaways

Camber Pharmaceuticals introduces Gabapentin Oral Solution, expanding its existing gabapentin product offerings.
Indications include management of postherpetic neuralgia in adults and adjunctive therapy for partial onset seizures in patients aged three and older.
The oral solution is available in a 470 mL bottle with a concentration of 250 mg per 5 mL.

Piscataway, NJ, October 25, 2024 – Camber Pharmaceuticals is pleased to announce the addition of Gabapentin Oral Solution to its product line. Camber also offers Gabapentin Tablets and Capsules.

Image credit: Camber Pharmaceuticals Inc.

Gabapentin Oral Solution is indicated for:

Management of Postherpetic Neuralgia in adults
Adjunctive therapy in the treatment of partial onset seizures, with and without secondary generalization, in adults and pediatric patients 3 years and older with epilepsy

Gabapentin Oral Solution is available in a 470 mL bottle with a concentration of 250 mg per 5 mL.

To learn more about Gabapentin Oral Solution, please visit https://www.camberpharma.com/gabapentinoralsolution